Yes, TNFs have been explored in various cancer therapies. For example, recombinant TNF-alpha has been used in isolated limb perfusion treatments for soft tissue sarcomas and melanoma. However, the systemic use of TNF-alpha is limited due to its severe side effects, including systemic inflammation and shock.